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Abstract
Background: Sexually transmitted infection (STI) screening programmes are implemented in many countries to
decrease burden of STI and to improve sexual health. Screening for Chlamydia trachomatis and Neisseria
gonorrhoeae has a prominent role in these protocols. Most of the screening programmes concerning men having
sex with men (MSM) are based on opportunistic urethral testing. In The Netherlands, a history-based approach is
used. The aim of this study is to evaluate the protocol of screening anatomic sites for C. trachomatis and N.
gonorrhoeae infection based on sexual history in MSM in routine practice in The Netherlands.
Methods: All MSM visiting the clinic for STI in The Hague are routinely asked about their sexual practice during
consulting. As per protocol, tests for urogenital, oropharyngeal and anorectal infection are obtained based on
reported site(s) of sexual contact. All consultations are entered into a database as part of the national STI
monitoring system. Data of an 18 months period were retrieved from this database and analysed.
Results: A total of 1455 consultations in MSM were registered during the study period. The prevalence of C.
trachomatis and N. gonorrhoeae per anatomic site was: urethral infection 4.0% respectively and 2.8%, oropharynx 1.5%
and 4.2%, and anorectum 8.2% and 6.0%. The majority of chlamydia cases (72%) involved a single anatomic site, which
was especially manifest for anorectal infections (79%), while 42% of gonorrhoea cases were single site. Twenty-six
percent of MSM with anorectal chlamydia and 17% with anorectal gonorrhoea reported symptoms of proctitis; none of
the oropharyngeal infections were symptomatic. Most cases of anorectal infection (83%) and oropharyngeal infection
(100%) would have remained undiagnosed with a symptom-based protocol.
Conclusions: The current strategy of sexual-history based screening of multiple anatomic sites for chlamydia and
gonorrhoea in MSM is a useful and valid guideline which is to be preferred over a symptom-based screening protocol.
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Background
Many countries have implemented national programmes
for screening for sexually transmitted infections (STI).
The aims of such programmes are to decrease the gen-
eral burden of STI, to improve physical and sexual
health, and to reduce transmission and acquisition of
STI. Screening for chlamydia and gonorrhoea has a pro-
minent place in these programmes and is done opportu-
nistically, i.e. regardless of the presence of symptoms,
because most of the cases are asymptomatic and there is
a low diagnostic accuracy of selective screening criteria
[1]. The screening of high-risk populations for urogen-
ital infection has been shown to be feasible and is asso-
ciated with clear reductions in the incidence of STI
[2-6].
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matis and Neisseria gonorrhoeae infection in MSM is test-
ing for urogenital infection through urine sample or
urethral swab. During the past decade, various studies from
the United States of America (USA) and Australia have
highlighted the importance of testing oropharyngeal and
anorectal samples in addition to urogenital tests in MSM
[7-14]. For example, a study in San Francisco showed that
53% of C. trachomatis and 64% of N. gonorrhoeae infections
in MSM involved nonurethral sites and would be missed if
screening was done only for urethral infection [7].
The present United Kingdom National Screening and
Testing Guidelines, Norwegian HIV and STI screening
protocols, Australian STI screening protocols, and guide-
lines from the Center for Disease Control and Prevention
include specific recommendations for screening for anor-
ectal and oropharyngeal infection in MSM based on
reported site of sexual contact [4-6,15-17]. The Dutch
Society for Dermatology and Venereology has similar
guidelines for screening for chlamydia and gonorrhoea in
MSM: a urethral or urine sample should be tested together
with an oropharyngeal sample in case fellatio is reported
and an anorectal sample if passive anorectal intercourse is
reported. Anorectal infections in MSM have special atten-
tion due to the identification of the lymphogranuloma
venereum strain L2b among MSM [18,19]. These tests
should be obtained regardless of the presence of symp-
toms. In contrast to the UK and CDC guidelines, testing
for oropharyngeal C. trachomatis infection is included in
the Dutch guidelines as optional. Data on the prevalence
of oropharyngeal chlamydia in MSM is limited, but in
most studies the prevalence is < 2% [7,20-22].
At the STI clinic in The Hague the guidelines of the
Dutch Society of Dermatology and Venereology are
used for screening for chlamydia and gonorrhoea in
M S M .T h e s eg u i d e l i n e si n c l u d ea n a t o m i cs i t es p e c i f i c
testing based on sexual history, including tests for oro-
pharyngeal C. trachomatis infection. While anatomic
site-specific STI testing in routine care has been evalu-
ated previously in some countries, only small studies
have been undertaken in Europe [7-14]. In addition, to
our knowledge only two studies have been conducted in
a European setting to assess the value of this approach,
but these included a relatively small number of MSM
(39 and 599, respectively) [21,22]. In the present study,
we evaluate the protocol of screening multiple anatomic
sites for chlamydia and gonorrhoea in a large cohort of
MSM at an STI clinic in the Netherlands to assess the
usefulness of this screening strategy in routine practice.
Methods
Study population
The STI Clinic in The Hague, The Netherlands offers
free and anonymous STI screening to people living in
t h ec i t yo fT h eH a g u ea n dt h es u r r o u n d i n gr e g i o n .
Approximately 15% of visitors to the clinic are MSM.
During routine consultation, sexual history is obtained
using a standard questionnaire. This questionnaire
includes questions about STI history, sexual practice,
number of sex partners, site(s) of sexual contact, and
symptoms that may be associated with STI. After coun-
selling, clients are routinely tested for chlamydia, gonor-
rhoea, syphilis, hepatitis B virus and HIV. The local
medical ethical committee approved this study, based on
the fact that in the Netherlands ethical approval is not
required for a retrospective, de-identified study.
Screening protocol
The following protocol is used routinely for screening
MSM for C. trachomatis and N. gonorrhoeae infection.
First-void urine is collected from all asymptomatic visi-
tors; a urethral swab is taken in case of penile discharge
or dysuria. If fellatio is reported in sexual history, an
oropharyngeal swab is obtained by wiping the swab
twice over the lateral posterior sides of the pharyngeal
wall followed by wiping once across the oropharyngeal
wall. If receptive anal intercourse is reported, an anorec-
tal sample is obtained by introducing a swab approxi-
mately 5 cm into the rectum under rotating movements.
The swaps were clinician-collected without the use of a
proctoscope.
Data collection
All consultations at the clinic are recorded in an anon-
ymous electronic file. This record includes basic demo-
graphic data, the routine questionnaire, results of
microbiological tests, diagnosis and treatment if applic-
able. After completion of the episode, all records are
transferred anonymously into a national database
(SOAP) for surveillance purposes. In this study, we
retrieved and retrospectively analysed data from the
SOAP database for the STI clinic in The Hague over an
18 month period (January 2007-July 2008).
Clinical definitions
We define urethral gonorrhoea or chlamydia as a posi-
tive test result for C. trachomatis or N. gonorrhoeae for
a urethral swab, or urine sample by PCR. Urethral infec-
tion was considered symptomatic in case of dysuria or
penile discharge. Pharyngeal chlamydia or gonorrhoea
was considered symptomatic in case of a sore throat
and rectal infection was defined symptomatic if anorec-
tal discharge, blood or mucus in the stools, tenesmus or
rectal pain was reported by the client.
Laboratory tests
Specific urethral, oropharyngeal and anorectal swabs
were used for specimen collection (APTIMA
®;G e n -
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anatomical site were collected in separate sample collec-
tion tubes. Testing of samples for C. trachomatis and N.
gonorrhoeae w a sd o n eu s i n gt h eA P T I M AC o m b o2
®
(AC2) assay (Gen-Probe Incorporated, San Diego, CA)
according to the manufacturer’s instructions. Positive
reactions for C. trachomatis and N. gonorrhoeae with
t h eA C 2a s s a yw e r ec o n f i r m e dw i t ht h eA P T I M AC T
(ACT) the APTIMA GC (ACG) assay respectively. Gen-
otyping for specific detection of the lymphogranuloma
venereum (LGV) strain was done on all anorectal sam-
ples with a positive result for C. trachomatis[23].
Statistical analysis
The SOAP database was evaluated for missing, incom-
plete and conflicting data and where possible cleaned by
reviewing free text in the records. Data were analyzed
using SPSS version 13.0 (SPSS Inc., Chicago, IL) and
described as numbers (%), proportion or median
(range). Categorical data were compared between groups
using Chi-square test and Fisher’s Exact test when
appropriate for categorical data and the Mann-Whitney
test for continuous data. Risk factors were described as
Odds ratio (OR) with 95% confidence interval (CI). The
distribution of prevalence of chlamydia and gonorrhoea
per anatomic site was depicted stratified by 5-year age
groups.
Results
Characteristics of study population
During the study period a total of 1455 consultations by
MSM were registered with complete data. This includes
three transgender men who registered as women, but
reported sexual contact with men and tests for male STI
screening were obtained. The median age was 38 years
old. The average sexual partners in the previous six
months was four; 29 were commercial sex workers; 358
consultations had history of STI, and 128 were notified
by a sexual partner. Clinical characteristics of the study
population are summarised in table 1.
Prevalence of chlamydia and gonorrhoea per anatomic
site
Based on sexual history, tests for urethral infection were
done in all except 4 consultations (99.7%); 1283 (88%)
MSM reported fellatio and had oropharyngeal swabs
taken while anorectal swabs were obtained from the
MSM who reported passive anorectal intercourse (n =
1141; 78%). In the majority of consultations (n = 1095)
samples were obtained from all three anatomic sites
(75%), while 16% had two sites tested (n = 230) and 130
(8.9%) had only tests done for urethral infection.
The overall prevalence of chlamydia was 10% and pre-
valence of gonorrhoea was 7.7%. The prevalence of C.
trachomatis at the individual anatomic sites was: urethra
4.0%, oropharynx 1.5% and anorectum 8.2%, and for N.
gonorrhoeae respectively 2.8%, 4.2% and 6.0% (Figure 1).
Rectal C. trachomatis infection was diagnosed in 94
cases and the LGV strain was found in 5 (3.1%); all of
these presented with symptoms of proctitis.
T h em a j o r i t yo fC. trachomatis infections (72%)
involved a single anatomic site in those MSM with two
or three anatomic sites tested. This was especially mani-
fest for anorectal infection where 79% of cases were lim-
ited to the anorectum. Sixty-five percent of cases of
urethral chlamydia and 53% of those with oropharyngeal
c h l a m y d i aw e r es i n g l es i t ei n f e c t i o n s .I nc o n t r a s t ,t h e
majority of N. gonorrhoeae cases (59%) involved multiple
anatomic sites: only 26% of urethral, 43% of anorectal
and 50% of oropharyngeal infections were limited to
that specific anatomic site.
Clinical presentation and risk factors
Symptoms were reported in the minority of consulta-
tions: 16% urethral, 4.5% anal and 1.4% pharyngeal,
while the majority of cases of chlamydia (56%) and
gonorrhoea (43%) did report symptoms. Predictive
values of specific STI symptoms for chlamydia and
gonorrhoea were low: urethritis was reported by 228
men (16%), but chlamydia was only diagnosed in 38
(17%) and gonorrhoea in 34 (15%). C. trachomatis infec-
tion was found in only 17 (26%) and N. gonorrhoeae in
11 (17%) of 65 individuals presenting with symptoms of
proctitis. None of the cases with oropharyngeal chlamy-
dia (n = 19) or gonorrhoea (n = 54) were symptomatic,
but symptoms of pharyngitis were reported by 20 MSM
without chlamydia or gonorrhoea. As such, if a symp-
tom-based protocol would have been used for screening
of anorectum and oropharynx, 121/145 (83%) of cases
with anorectal infection and 68/68 (100%) of those with
oropharyngeal infection would have remained
undiagnosed.
Median age of MSM with anorectal chlamydia or
gonorrhoea was significantly higher than of those with-
out anorectal infection (40 vs.3 7y e a r s ;p=0 . 0 2 ) ;t h i s
association was not observed for urethral (p = 0.6) or
oropharyngeal (p = 0.4) infection. Figure 2 shows the
prevalence of C. trachomatis and N. gonorrhoeae per
anatomic site stratified by age group. The figure shows
that the prevalence of anorectal infections is highest in
the older age-groups whereas detection of urethral
infections remains stable throughout.
The reported number of sexual partners in the period
of 6 months prior to consultation was higher by MSM
with chlamydia (mean 12 vs.8 . 2 ;p=0 . 0 3 )o rg o n o r -
rhoea (11 vs. 8.4; p = 0.03) than those without infection.
This was especially related to anorectal infection (13 vs.
8.6; p = 0.02) but not the case for urethral (p = 0.5) and
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of STI was a risk factor for chlamydia or gonorrhoea
infection at each anatomic site: urethra (OR 1.7 (95%
1.1-2.7); p = 0.02), oropharynx (OR 2.0 (95% CI 1.2-3.3);
p < 0.01), and anorectum (OR 2.2 (95% CI 1.5-2.1); p <
0.001). In those with known HIV status (n = 1206), HIV
infection was associated with increased risk for chlamy-
dia (OR 2.5 (95% CI 1.6-4.0); p < 0.001) and gonorrhoea
(OR 3.6 (95% CI, 2.2-6.0); p < 0.001). HIV seropositive
status was especially associated with anorectal infection
(OR 3.6 (95% CI 2.2-5.6); p < 0.001), to a lesser extent
with urethral infection (OR 1.9 (95% CI 1.0-3.5); p =
0.04) and not with oropharyngeal infection (p = 0.1).
Discussion
This study shows that testing of multiple anatomic sites
for chlamydia and gonorrhoea based on sexual history is
a useful strategy for screening for chlamydia and
gonorrhoea in MSM. Our data support previous reports
and national guidelines that suggest benefit of testing
swabs obtained from oropharynx and anorectum in
addition to urethral samples in MSM [4-14,21,22].
T h ep r e v a l e n c eo fC. trachomatis and N. gonorrhoeae
infection of oropharynx and anorectum in our study is
in line with data reported by others [7-14,21,22]. Similar
to those studies, we also found that urethral infections
only represent a minority of cases and that anorectal
infection is more common. In our setting, the preva-
lence of chlamydia and gonorrhoea more than doubled
with testing of multiple anatomic sites compared to
obtained tests for urethral infection alone. The majority
of C. trachomatis infections involved a single anatomic
site, which was especially the case for anorectal chlamy-
dia, while only a small majority of N. gonorrhoea infec-
tions involved multiple sites. Altogether, our data
strongly support the current guidelines that suggest
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Figure 1 Prevalence of Chlamydia trachomatis and Neisseria gonorrhoea infection per anatomic site in MSM. MSM, men who have sex
with men.
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Page 4 of 7screening anorectum and oropharyngeal samples based
on sexual history in addition to urethral tests
[4-6,15,16,18].
The prevalence of C. trachomatis in oropharyngeal
samples was 1.5% which was in similar range as
reported for a cohort of women reporting fellatio in the
same setting [24]. Although there is sufficient evidence
to screen for oropharyngeal gonorrhoea, there is
ongoing debate about the relevance of screening for oro-
pharyngeal Chlamydia [25-28]. This debate is about the
prevalence and transmissibility of oropharyngeal C. tra-
chomatis infection. The exact risk of transmission of C.
trachomatis from throat to penis in fellatio is unknown,
but a recent study suggests this may be quite consider-
able [29]. Altogether, in the absence of clear data about
risk of transmission, it seems reasonable to include tests
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Figure 2 Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae infection per anatomic site stratified by age groups.
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protocol. Oropharyngeal swabs could be tested simulta-
neously for N. gonorrhoeae and C. trachomatis if a
nuclear amplification test is used. In that regard, cost-
effectiveness analyses are warranted; a possible method
to reduce costs would be to combine swabs from differ-
ent anatomic sites in a single collection tube and to test
these samples simultaneously in a single reaction [30].
The current protocol of opportunistic screening of
anatomic sites based on sexual history has a much bet-
ter performance than theoretically would have been
obtained with a screening strategy based on reported
symptoms. The vast majority of C. trachomatis and N.
gonorrhoeae infections were asymptomatic, regardless of
the anatomic site involved. In addition, the positive pre-
dictive values of proctitis and pharyngitis are very low.
As such, opportunistic screening is superior to symp-
tom-based screening. We used reported sexual exposure
as indication for obtaining anatomic site specific tests.
This approach is in line with the current guidelines, but
the reliability of sexual history in this context is unclear.
Some men may not report exposure for reasons of
stigma or embarrassment. An Australian study [31]
states that approximately half of the anorectal infections
were self-reported, where half were diagnosed by oppor-
tunistic screening. Thus an alternative strategy is oppor-
tunistic screening of all anatomic sites in all MSM
regardless of reported exposure. Considering that the
vast majority of our clients reported sexual contact at all
t h r e ea n a t o m i cs i t e s ,t h a tM S Mc a nb ev e r yo u t s p o k e n
about their sexual practice (e.g. deny ever engaging in
receptive anorectal intercourse), that the expected pre-
valence of infection at anatomic sites that were not
exposed during sexual contact is low, and the physical
burden of obtaining tests from patients denying sexual
contact at that specific body site, we believe that oppor-
tunistic screening of multiple anatomic sites in all MSM
is unlikely of additional value to sexual-history based
screening protocol. Nevertheless, studies are warranted
to confirm this hypothesis.
In this retrospective analysis we found that higher
number of sexual partners, history of STI, and HIV
seropositive status were risk factors for chlamydia and
gonorrhoea infection at any anatomic site. These are
known risk factors for STI and markers of high risk
sexual behaviour. Risk factors associated with anorectal
infection were older age, higher number of sexual part-
ners, and HIV seropositive status. Our results show an
increasing prevalence of both anorectal chlamydia and
gonorrhoea infections with increasing age. As such,
specific attention should be given to preventive mea-
sures and anorectal screening in MSM with those
characteristics.
This study has several limitations. First, one client can
be included in the database with multiple visits related
to different consultations due to the set-up and anon-
ymous character of the database. Based on some vari-
ables (age, postal code, and ethnicity), we estimate that
90% of the consultations are unique and 10% are multi-
p l ev i s i t s .T h e s em u l t i p l ev isits may have introduced
some bias when calculating risk factors for chlamydia
and gonorrhoea at specific anatomical sites, because
those are related to risk behaviour. Secondly, the data
presented were collected during routine clinical consul-
tations and only informationi n c l u d e di nt h es t a n d a r d
questionnaire was captured systematically. For example,
the report of pharyngitis was only recorded if the patient
complained about a sore throat, but not specifically
asked for. As such, more studies are warranted to con-
firm our findings.
Conclusions
Our data indicate that the current strategy of sexual-his-
tory based screening of multiple anatomic sites in MSM
is a useful and valid guideline for screening for chlamy-
dia and gonorrhoea in MSM and that this approach is
superior to a symptom-based screening protocol. Speci-
fic attention should be given during consultation to
information, prevention and anorectal screening of older
MSM, those with a relatively high number of sexual
partners, and those with HIV seropositive status.
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